Keyphrases
18F-fluorodeoxyglucose (18F-FDG)
8%
18F-fluorodeoxyglucose Positron Emission Tomography (18F-FDG PET)
100%
Active Sites
8%
Biopsy Specimen
8%
Chemoembolization
8%
Cirrhosis
16%
Clinical Data
8%
Clinical High Risk
8%
Clinically Significant
8%
Consecutive Patients
8%
Direct Therapy
8%
Distant Metastasis
8%
Fluorodeoxyglucose
58%
Fluorodeoxyglucose Positron Emission Tomography (FDG-PET)
66%
General Electric
8%
Hepatic Lesion
8%
Hepatocellular Carcinoma
100%
Hepatocellular Carcinoma Recurrence
8%
Histological Grade
16%
Intratumoral Fibrosis
16%
Intravenous Administration
8%
Knoxville
8%
Liver Transplant Recipients
8%
Locoregional Therapy
8%
Medical Systems
8%
Metabolically Active
8%
Metastasis
8%
Metastatic Disease
8%
Milwaukee
8%
Necrosis
8%
Necrotic Tumor
8%
Patient Management
8%
Patient Selection
8%
Phosphatase Activity
8%
Positron Emission Tomography
100%
Resection Specimen
8%
Response Monitoring
8%
Response to Treatment
8%
Retrospective Review
8%
Siemens
8%
Treatment Monitoring
8%
Tumor Biopsy
8%
Tumor Necrosis
8%
Tumor Resection
8%
Nursing and Health Professions
Biopsy
6%
Cancer Surgery
6%
Chemoembolization
6%
Distant Metastasis
6%
Fibrosis
13%
Fluorodeoxyglucose
100%
Fluorodeoxyglucose F 18
100%
Imaging
6%
Liver Cell Carcinoma
100%
Liver Cirrhosis
13%
Liver Graft
6%
Liver Injury
6%
Metastasis
6%
Necrosis
6%
Neoplasm
6%
Phosphatase
6%
Positron Emission Tomography
100%
Recurrent Disease
26%
Tumor Biopsy
6%
Tumor Necrosis
6%
Medicine and Dentistry
Biopsy
6%
Cancer Surgery
6%
Distant Metastasis
6%
Fibrosis
13%
Fluorodeoxyglucose
100%
Fluorodeoxyglucose F 18
100%
Hepatocellular Carcinoma
100%
Liver Cirrhosis
13%
Liver Graft
6%
Liver Injury
6%
Metastatic Carcinoma
13%
Necrosis
6%
Neoplasm
6%
Phosphatase
6%
Positron Emission Tomography
100%
Recurrent Disease
26%
Transcatheter Arterial Chemoembolization
6%
Tumor Biopsy
6%
Tumor Necrosis
6%
Pharmacology, Toxicology and Pharmaceutical Science
Distant Metastasis
6%
Fibrosis
13%
Fluorodeoxyglucose
100%
Fluorodeoxyglucose F 18
100%
Liver Cell Carcinoma
100%
Liver Cirrhosis
13%
Liver Injury
6%
Metastasis
6%
Necrosis
6%
Neoplasm
13%
Phosphatase
6%
Recurrent Disease
26%
Tumor Necrosis
6%
Immunology and Microbiology
Positron Emission Tomography
100%
Transplant Procedure
7%